NCT00699192
Safety, Tolerability, and Efficacy of Once Daily Amlodipine/Valsartan 5/80 as Compared to Amlodipine/Valsartan 5/40 or to Amlodipine 5 mg Monotherapy in Patients 65 Years of Age and Older With Essential Hypertension
See it on ClinicalTrials.gov ↗819 people
52.7%
47.3%
432 womenmiddle line = equal numbers387 men
- Phase
- PHASE3
- Paid for by
- Novartis Pharmaceuticals
- Finished
- 2009-05
- Health conditions
- Hypertension
- Who could join
- Anyone
- Ages
- 65 Years – no maximum
- Average age
- mean 71.6 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- Only women past menopause
Women who could still get pregnant were turned away.
“Female patients had to be post-menopausal for at least one year.”
- No kidney or liver problems
Women with kidney or liver problems were turned away.
“Significant hepatic disease, as demonstrated by any one of the following: aspartate aminotransferase (AST) or alanine aminotransferase (ALT) values greater than two times the upper limit of normal at Visit 1, a history of hepatic encephalop…”
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“Significant history of coronary artery disease (CAD) such as any history of myocardial infarction (MI), angina pectoris, and all types of revascularization procedures.”
- No diabetes
Women with diabetes were turned away.
“All patients with Type 1 diabetes mellitus and those patients with Type 2 diabetes mellitus who, in the opinion of the investigator, were not well controlled. Patients who needed oral anti-diabetic medication to adequately control their Typ…”
- No cancer
Women with current or past cancer were turned away.
“Known moderate or malignant retinopathy. Moderate was defined as retinal signs of hemorrhage, microaneurysm, cotton-wool spot, hard exudates, or a combination thereof; malignant defined as signs of moderate retinopathy plus swelling of the…”
Study titles and rules are shown in their original English.